Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
On good news this should jump like SNG did back in 2020 300%
then continue upwards to 500%,
thats intraday....
Contracts due anyday as Testing of Heart Valve started in December.
RUA Life sciences to disrupt $10 billion dollar industry!
time to research over the weekend and decide Monday before it's late.
GLA
Recipes for 20 Bagger
🔹Tiny company
💲Distrupting big industry $10 billion dollar per year)
🔹New tech
Wow !! 20 X Potential !
#RUA
London listed, to disrupt current Heart Valve market $10 Billion per year) 😯
Current Sp 10p £6m Mcap
Broker target £120m
That's 20X return
Market makers gifting this company to buy at this crazy low prices.
Mms not realise the potential of This company
when Investors wake up, this should do rises like these below mentioned companies in the past
NCYT
EUA
SNG
Prem
EEE
PTAL
INDV
etc.......
research before Herds cotton on the potential here.
Https://twitter.com/EquityTrader888/status/1783777561253642523?t=jMX_Y48p_aSXZGRssUIq_g&s=19
FDA man at RUA board of director
heart valve expert
this should be hitting £50m MCap soon.
matter of time
Wow......
one of the Board director has been working for FDA for 7 years and has heart valve experience and the expertise.......
join the dots......
why would Material testing agreement was done in December?
you don't get expert selling a product to another expert without both are sure this will work!
Davy50
stop getting personal
I'm saying this deal is a big slap on the face of Angle shareholders and
I would've shown AstraZeneca the door for this Contempt money.
why management even accepted this sort of peanuts money from a $4Billion+company?
utter disgraceful the Board of directors.
Davy50
stop getting person,
I'm saying this deal is a big slap on the face of Angle shareholders and
I would've shown AstraZeneca the door for this Contempt money.
why management even accepted this sort of peanuts money from a $4Billion+company?
utter disgraceful the Board of directors.
Davy50
when I see a bargain I buy truck loads......
You think AstraZeneca Scientist don't know what Angle has to offer?
a cheap £150k worth of trails for 6 months,
that's what's its worth
hence AstraZeneca not paying a dime more.
AstraZeneca not stupid
had they seen the value they would have took the whole thing
it's not worth it
How is this transformative?
, with £30m debt
cash £6m
mms risen this, after few sells this goes down......
bullish rns doesn't match the debt issue
£30m debt
this will take another 5:years to clear....... look at the rns
per year they managed on £4m to clear debt
20 December 2023
20 December 2023
RUA Life Sciences Plc
("RUA Life Sciences", the "Company" or the "Group")
Heart Valve Leaflet Material - Testing Update
RUA Life Sciences (AIM: RUA), the holding company of a group of medical device businesses focused on the exploitation of the world's leading long-term implantable biostable polymer (Elast-Eon?), today provides an update on recent developments of the RUA leaflet composite.
The objective for RUA Structural Heart during 2023 was to evaluate heart valve leaflet material and compare the performance of 100% polymeric valves with the novel composite developed by the Group. The computational modelling of the composite material at the design stage suggested that its mechanical properties would be ideal for heart valve leaflets.
Testing undertaken by RUA has demonstrated:
· Flex fatigue stability over 400m cycles
· Durability as a heart valve leaflet over 200m cycles
· Remarkable tensile strength properties exceeding both base fabric and polymer
· Similar tensile strength in multiple directions
· Highly flexible allowing improved valve efficiency.
· Narrow crimping profile allowing TAVR benefits
· Retention of ElastEon blood contacting properties such as calcification and thrombogenicity.
· Material very stable with no delamination during testing and high tear resistance.